Diffuse Alveolar Hemorrhage after Adalimumab Treatment of Rheumatoid Arthritis / 대한내과학회지
Korean Journal of Medicine
;
: 439-444, 2013.
Artículo
en Coreano
| WPRIM
| ID: wpr-169739
ABSTRACT
Diffuse alveolar hemorrhage (DAH) is a life-threatening condition involving hemorrhage originating in the pulmonary microvasculature. The clinical syndrome is characterized by hemoptysis, hypoxemic respiratory failure, low-grade fever, and diffuse pulmonary infiltrates. The majority of cases of DAH are caused by pulmonary renal syndromes, connective tissue disorders, and drugs. Here, we present a case of DAH associated with adalimumab treatment in a patient with rheumatoid arthritis.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Artritis Reumatoide
/
Insuficiencia Respiratoria
/
Tejido Conectivo
/
Microvasos
/
Fiebre
/
Anticuerpos Monoclonales Humanizados
/
Adalimumab
/
Hemoptisis
/
Hemorragia
Límite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS